JP2019527209A5 - - Google Patents

Download PDF

Info

Publication number
JP2019527209A5
JP2019527209A5 JP2018569157A JP2018569157A JP2019527209A5 JP 2019527209 A5 JP2019527209 A5 JP 2019527209A5 JP 2018569157 A JP2018569157 A JP 2018569157A JP 2018569157 A JP2018569157 A JP 2018569157A JP 2019527209 A5 JP2019527209 A5 JP 2019527209A5
Authority
JP
Japan
Prior art keywords
formula
natural number
drug conjugate
group
null
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018569157A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019527209A (ja
JP6937329B2 (ja
Filing date
Publication date
Priority claimed from GB1611405.0A external-priority patent/GB2551979A/en
Application filed filed Critical
Publication of JP2019527209A publication Critical patent/JP2019527209A/ja
Publication of JP2019527209A5 publication Critical patent/JP2019527209A5/ja
Application granted granted Critical
Publication of JP6937329B2 publication Critical patent/JP6937329B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018569157A 2016-06-30 2017-06-15 切断可能なポリマー薬物コンジュゲート Active JP6937329B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1611405.0A GB2551979A (en) 2016-06-30 2016-06-30 Cleavable polymer drug conjugates
GB1611405.0 2016-06-30
PCT/IB2017/053567 WO2018002761A1 (en) 2016-06-30 2017-06-15 Cleavable polymer drug conjugates

Publications (3)

Publication Number Publication Date
JP2019527209A JP2019527209A (ja) 2019-09-26
JP2019527209A5 true JP2019527209A5 (enExample) 2020-07-27
JP6937329B2 JP6937329B2 (ja) 2021-09-22

Family

ID=56891421

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018569157A Active JP6937329B2 (ja) 2016-06-30 2017-06-15 切断可能なポリマー薬物コンジュゲート

Country Status (19)

Country Link
US (1) US20190321479A1 (enExample)
EP (2) EP4260874A1 (enExample)
JP (1) JP6937329B2 (enExample)
KR (3) KR20230035709A (enExample)
CN (1) CN109475637A (enExample)
AU (1) AU2017286869B2 (enExample)
CA (1) CA3029318A1 (enExample)
DK (1) DK3478323T3 (enExample)
EA (1) EA038984B1 (enExample)
ES (1) ES2966774T3 (enExample)
FI (1) FI3478323T3 (enExample)
GB (1) GB2551979A (enExample)
HR (1) HRP20231642T1 (enExample)
HU (1) HUE064705T2 (enExample)
IL (3) IL321408A (enExample)
MX (2) MX2019000277A (enExample)
PL (1) PL3478323T3 (enExample)
PT (1) PT3478323T (enExample)
WO (1) WO2018002761A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765432B2 (en) 2009-12-18 2014-07-01 Oligasis, Llc Targeted drug phosphorylcholine polymer conjugates
GB2556055B (en) 2016-11-16 2022-03-23 Rs Arastirma Egitim Danismanlik Ilac Sanayi Ticaret Ltd Sti Self-assembled diblock copolymers composed of pegmema and drug bearing polymeric segments
US12150996B2 (en) * 2017-11-17 2024-11-26 Centre National De La Recherche Scientifique Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof
CN108752507A (zh) * 2018-05-12 2018-11-06 辽宁大学 一种酶敏感和氧化还原敏感双重响应型共聚物及其制备方法和应用
TR201911542A2 (tr) * 2019-07-30 2021-02-22 Bogazici Ueniversitesi Anti̇kor-poli̇mer konjugatlari
JP2022549680A (ja) * 2019-09-26 2022-11-28 スターファーマ ピーティーワイ エルティーディー 治療用デンドリマー
CN112608364B (zh) * 2020-12-09 2023-08-29 四川瀛瑞医药科技有限公司 一种果胶-阿霉素轭合物及其中间体的制备方法
CN115010913B (zh) * 2022-06-17 2023-05-26 广东工业大学 一种pH/还原双重响应聚合物胶束及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19636889A1 (de) 1996-09-11 1998-03-12 Felix Dr Kratz Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel
ATE317703T1 (de) 1997-06-12 2006-03-15 Innovata Plc Polymer-wirkstoff-konjugate zur behandlung von krebs
CN1308347C (zh) 1999-04-28 2007-04-04 德克萨斯大学董事会 用于通过选择性抑制vegf来治疗癌症的组合物和方法
US20030215395A1 (en) 2002-05-14 2003-11-20 Lei Yu Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
CZ2005558A3 (cs) * 2005-09-05 2007-04-04 Zentiva, A. S. Zpusob prípravy polymerních konjugátu doxorubicinu s pH-rízeným uvolnováním léciva
US8017141B2 (en) * 2006-12-15 2011-09-13 Advanced Cardiovascular Systems, Inc. Coatings of acrylamide-based copolymers
AU2009302387B2 (en) * 2008-10-07 2014-12-04 Rexahn Pharmaceuticals, Inc HPMA - docetaxel or gemcitabine conjugates and uses therefore
CZ303072B6 (cs) * 2009-02-13 2012-03-21 Zentiva, K.S. Polymerní konjugáty paclitaxelu a docetaxelu s pH rízeným uvolnováním kancerostatika
BR112012008772A2 (pt) * 2009-10-13 2017-06-20 Rexahn Pharmaceuticals Inc sistemas poliméricos para a liberação de agentes anti-câncer
WO2012014003A1 (en) * 2010-07-28 2012-02-02 Corning Incorporated Pre-polymer preparations for cell culture coatings
WO2014152451A2 (en) * 2013-03-14 2014-09-25 University Of Rochester Compositions and methods for controlled localized delivery of bone forming therapeutic agents
CN105168230B (zh) * 2015-09-02 2019-01-22 上海市普陀区中心医院 一种具有内涵体逃逸功能的肿瘤靶向前药及其纳米制剂和制备方法

Similar Documents

Publication Publication Date Title
JP2019527209A5 (enExample)
KR101705077B1 (ko) Hpma-도세탁셀 또는 젬시타빈 컨쥬게이트 및 이의 용도
ES2966774T3 (es) Conjugados polímero-fármaco escindibles
JP2019535710A5 (enExample)
KR101721865B1 (ko) 항암제의 전달을 위한 폴리머 시스템
JP7467548B2 (ja) Pegmema及び薬物担持ポリマーセグメントから構成される自己集合化ジブロックコポリマー
KR20100087116A (ko) 하이드록시아파타이트-표적 다중팔 중합체 및 그로부터 제조된 컨쥬게이트
ES2458841T3 (es) Portadores de fármacos de polímero de alto peso molecular dendrítico y sus conjugados con fármacos especialmente para el tratamiento de tumores sólidos
US9192677B2 (en) Biodegradable, water soluble and pH responsive poly(organo)phosphazenes
CZ2016206A3 (cs) Blokový kopolymer pro překonání lékové rezistence nádorů k chemoterapii, jeho polymerní konjugát s léčivem, farmaceutická kompozice je obsahující, způsob jejich přípravy a jejich použití
BR112019000029B1 (pt) Conjugado polímero-fármaco, métodos para preparar o mesmo, composição farmacêutica que compreende o dito conjugado, bem como o uso do mesmo para o tratamento e/ou a profilaxia de câncer